NPI: 1467469023 · BROOKLYN, NY 11206 · Internal Medicine Physician · NPI assigned 08/03/2006
Authorized official KARLIN, MARJI controls 19+ related entities in our dataset. Read more
| Authorized Official | KARLIN, MARJI (CHIEF REVENUE OFFICER) |
| NPI Enumeration Date | 08/03/2006 |
Other providers sharing the same authorized official: KARLIN, MARJI
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 73,077 | $568K |
| 2019 | 213,644 | $7.31M |
| 2020 | 421,094 | $19.24M |
| 2021 | 636,499 | $26.80M |
| 2022 | 620,143 | $27.59M |
| 2023 | 454,295 | $19.89M |
| 2024 | 409,006 | $17.87M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 97,080 | 90,734 | $14.05M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 158,992 | 135,529 | $11.47M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 69,774 | 64,122 | $11.22M |
| 90791 | Psychiatric diagnostic evaluation | 11,189 | 9,546 | $7.77M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 71,281 | 62,936 | $5.81M |
| 90832 | Psychotherapy, 30 minutes with patient | 37,086 | 27,368 | $4.29M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 18,781 | 17,664 | $2.92M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 44,485 | 39,220 | $2.49M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13,419 | 12,722 | $2.21M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 32,956 | 29,275 | $2.17M |
| 90834 | Psychotherapy, 45 minutes with patient | 11,335 | 7,601 | $1.82M |
| D0999 | Unspecified diagnostic procedure, by report | 10,854 | 10,610 | $1.73M |
| 70450 | Computed tomography, head or brain; without contrast material | 10,757 | 10,460 | $1.69M |
| 36415 | Collection of venous blood by venipuncture | 186,584 | 120,149 | $1.49M |
| 96361 | Intravenous infusion, hydration; each additional hour | 15,778 | 12,772 | $1.34M |
| S9485 | Crisis intervention mental health services, per diem | 1,059 | 875 | $1.19M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 16,422 | 15,733 | $1.17M |
| D9999 | Unspecified adjunctive procedure, by report | 8,387 | 7,809 | $1.16M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 10,404 | 10,133 | $1.11M |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 7,320 | 7,140 | $1.09M |
| 81412 | 617 | 616 | $963K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 29,216 | 28,206 | $867K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,137 | 1,110 | $820K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 8,464 | 7,408 | $817K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 14,029 | 13,867 | $813K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 15,383 | 4,591 | $787K |
| 99215 | Prolong outpt/office vis | 5,186 | 4,789 | $739K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 27,424 | 27,330 | $692K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 25,669 | 24,723 | $674K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 6,636 | 6,568 | $655K |
| 80053 | Comprehensive metabolic panel | 67,458 | 62,898 | $641K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 18,307 | 15,570 | $577K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 32,031 | 27,741 | $564K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 4,161 | 4,015 | $557K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 4,559 | 4,343 | $555K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 7,162 | 6,700 | $554K |
| 99442 | 10,514 | 9,889 | $548K | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 792 | 787 | $542K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 30,149 | 25,314 | $514K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3,293 | 3,235 | $483K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 3,301 | 3,216 | $459K |
| 86480 | 7,842 | 7,647 | $459K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 3,667 | 3,269 | $447K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 1,052 | 1,044 | $442K |
| 87536 | 5,024 | 4,920 | $431K | |
| 76641 | 4,158 | 3,532 | $406K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 479 | 463 | $393K |
| 80061 | Lipid panel | 37,208 | 36,539 | $380K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 5,988 | 5,550 | $367K |
| 41899 | Unlisted procedure, dentoalveolar structures | 466 | 464 | $365K |
| 90461 | 12,013 | 11,994 | $351K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4,068 | 3,982 | $344K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 17,126 | 15,073 | $344K |
| 85027 | 101,496 | 94,083 | $339K | |
| 59025 | Fetal non-stress test | 3,664 | 2,752 | $338K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 7,084 | 2,554 | $329K |
| 86360 | 6,981 | 6,855 | $322K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 4,976 | 4,854 | $310K |
| 71046 | Radiologic examination, chest; 2 views | 19,795 | 19,222 | $306K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 4,185 | 3,641 | $300K |
| 83036 | Hemoglobin; glycosylated (A1C) | 43,987 | 42,918 | $300K |
| 99443 | 3,897 | 3,287 | $284K | |
| G0397 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes | 1,651 | 722 | $282K |
| 76818 | 3,415 | 2,057 | $279K | |
| H0037 | Community psychiatric supportive treatment program, per diem | 270 | 239 | $278K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 31,630 | 30,967 | $276K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 5,801 | 5,652 | $272K |
| 84443 | Thyroid stimulating hormone (TSH) | 23,573 | 22,871 | $261K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 12,856 | 12,330 | $261K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 1,300 | 1,275 | $261K |
| 99441 | 9,758 | 8,795 | $256K | |
| 86703 | 20,385 | 20,019 | $255K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2,676 | 2,650 | $252K |
| 86359 | 7,073 | 6,945 | $251K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 26,435 | 24,638 | $250K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6,567 | 6,153 | $248K |
| D7140 | Extraction, erupted tooth or exposed root | 9,111 | 6,399 | $247K |
| 70486 | 1,798 | 1,764 | $245K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,008 | 1,989 | $236K |
| 76830 | Ultrasound, transvaginal | 2,683 | 2,580 | $235K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8,910 | 8,640 | $233K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,209 | 2,143 | $225K |
| 0002A | 7,419 | 7,389 | $223K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 27,119 | 25,900 | $220K |
| 90750 | 2,673 | 2,645 | $214K | |
| 82962 | 42,867 | 31,603 | $213K | |
| 0001A | 7,620 | 7,610 | $211K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 3,383 | 2,545 | $209K |
| 90677 | 1,792 | 1,788 | $202K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 2,902 | 2,802 | $201K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 9,676 | 9,549 | $193K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2,753 | 2,436 | $187K |
| 93970 | 1,106 | 1,085 | $181K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 5,910 | 4,549 | $177K |
| 11721 | 5,614 | 4,831 | $176K | |
| 76801 | 1,782 | 1,759 | $171K | |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 2,516 | 480 | $170K |
| 12001 | 813 | 785 | $169K | |
| 99205 | Prolong outpt/office vis | 922 | 896 | $164K |
| 86769 | 4,391 | 4,255 | $158K | |
| 86850 | 9,653 | 9,025 | $157K | |
| H0050 | Alcohol and/or drug services, brief intervention, per 15 minutes | 2,412 | 2,274 | $154K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 6,375 | 5,916 | $149K |
| 90697 | 1,780 | 1,779 | $149K | |
| 90715 | 6,449 | 6,407 | $148K | |
| 12011 | 735 | 723 | $148K | |
| 76770 | 1,155 | 1,117 | $148K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 317 | 314 | $147K |
| 99201 | 2,227 | 2,094 | $144K | |
| 97162 | 1,483 | 1,474 | $143K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 1,727 | 1,721 | $140K |
| 92015 | Determination of refractive state | 6,076 | 6,048 | $139K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 21,941 | 20,110 | $137K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2,633 | 2,577 | $130K |
| 99381 | 1,373 | 1,366 | $128K | |
| 71045 | Radiologic examination, chest; single view | 16,020 | 15,230 | $128K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5,926 | 5,743 | $127K |
| 77066 | Tomosynthesis, mammo | 816 | 812 | $122K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 184 | 182 | $121K |
| 86803 | 11,448 | 11,306 | $119K | |
| 83655 | 9,941 | 9,767 | $119K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 790 | 784 | $117K |
| D0120 | Periodic oral evaluation - established patient | 11,439 | 10,942 | $117K |
| 96127 | 28,681 | 24,483 | $116K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 9,177 | 8,529 | $112K |
| D0140 | Limited oral evaluation - problem focused | 11,689 | 10,222 | $111K |
| 86780 | 10,167 | 9,890 | $110K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,675 | 1,635 | $109K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1,105 | 1,082 | $109K |
| 90686 | 11,632 | 11,557 | $108K | |
| 90651 | 1,634 | 1,620 | $103K | |
| 92250 | 2,992 | 2,609 | $102K | |
| 80076 | 16,385 | 15,985 | $102K | |
| 90746 | 1,842 | 1,829 | $101K | |
| 77065 | Tomosynthesis, mammo | 843 | 817 | $101K |
| 86901 | 9,700 | 9,044 | $97K | |
| 73630 | 4,625 | 4,201 | $95K | |
| 71271 | 387 | 382 | $95K | |
| H0014 | Alcohol and/or drug services; ambulatory detoxification | 502 | 223 | $83K |
| 76819 | Fetal biophysical profile; without non-stress testing | 2,395 | 2,207 | $83K |
| 90734 | 1,358 | 1,340 | $82K | |
| D1120 | Prophylaxis - child | 8,024 | 8,024 | $82K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4,481 | 4,432 | $78K |
| 87535 | 2,284 | 2,263 | $78K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,735 | 1,698 | $75K |
| H0038 | Self-help/peer services, per 15 minutes | 3,109 | 2,851 | $74K |
| 97010 | 9,401 | 2,668 | $74K | |
| 86900 | 9,684 | 9,025 | $73K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 4,806 | 4,745 | $73K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,663 | 3,515 | $71K |
| 71250 | 353 | 353 | $70K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 9,081 | 8,575 | $68K |
| 73564 | 2,489 | 2,372 | $67K | |
| 99385 | 862 | 848 | $67K | |
| 81001 | 33,740 | 31,307 | $67K | |
| D1110 | Prophylaxis - adult | 4,198 | 4,148 | $67K |
| 86706 | 7,801 | 7,588 | $65K | |
| 97802 | 2,649 | 2,610 | $65K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2,216 | 2,155 | $63K |
| 10060 | 367 | 321 | $61K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1,596 | 1,550 | $61K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 916 | 907 | $61K |
| 0004A | 1,591 | 1,588 | $58K | |
| 72100 | 2,360 | 2,321 | $58K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 326 | 322 | $57K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1,730 | 1,690 | $57K |
| 87340 | 7,764 | 7,549 | $56K | |
| J2794 | Injection, risperidone (risperdal consta), 0.5 mg | 77 | 54 | $56K |
| 92083 | 1,149 | 998 | $56K | |
| 92550 | 1,679 | 1,598 | $56K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 11,956 | 11,100 | $56K |
| 81025 | 18,601 | 17,766 | $56K | |
| 87800 | 1,809 | 1,785 | $55K | |
| H0001 | Alcohol and/or drug assessment | 280 | 160 | $52K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 6,520 | 6,445 | $52K |
| 86762 | 4,013 | 3,876 | $51K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 1,372 | 1,284 | $51K |
| 99401 | 2,022 | 1,929 | $49K | |
| 86765 | 4,389 | 4,231 | $48K | |
| 84439 | 6,581 | 6,393 | $48K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 205 | 194 | $48K |
| 84702 | 8,967 | 7,857 | $48K | |
| 59425 | 733 | 674 | $47K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | 1,295 | 824 | $46K |
| 73610 | 2,412 | 2,289 | $45K | |
| D0220 | Intraoral - periapical first radiographic image | 11,578 | 11,443 | $45K |
| 90670 | 3,775 | 3,766 | $45K | |
| J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | 67 | 63 | $45K |
| 87486 | 2,695 | 2,669 | $44K | |
| 99386 | 459 | 450 | $44K | |
| 93247 | 252 | 251 | $44K | |
| 73030 | 2,291 | 2,196 | $42K | |
| 83880 | 3,184 | 3,078 | $41K | |
| 92133 | 1,406 | 1,235 | $41K | |
| 73130 | 2,384 | 2,260 | $41K | |
| 82728 | 3,876 | 3,803 | $40K | |
| 93017 | 778 | 766 | $40K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1,444 | 1,441 | $40K |
| 0003A | 1,004 | 1,004 | $40K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 84 | 83 | $39K |
| 90732 | 420 | 410 | $39K | |
| 85610 | 12,024 | 10,384 | $38K | |
| 84153 | 2,765 | 2,718 | $38K | |
| 74019 | 1,182 | 1,163 | $38K | |
| 92134 | 1,172 | 1,079 | $37K | |
| 86787 | 3,777 | 3,653 | $37K | |
| 82951 | 3,509 | 3,250 | $37K | |
| 92579 | 662 | 660 | $36K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,051 | 3,545 | $36K |
| 86593 | 10,153 | 9,813 | $35K | |
| 99051 | 4,327 | 4,290 | $35K | |
| 97165 | 353 | 353 | $35K | |
| D0150 | Comprehensive oral evaluation - new or established patient | 3,382 | 3,184 | $35K |
| D1208 | Topical application of fluoride, excluding varnish | 9,000 | 8,986 | $35K |
| 91320 | 465 | 462 | $34K | |
| 96161 | 4,518 | 4,334 | $34K | |
| 83020 | 2,561 | 2,455 | $33K | |
| D0274 | Bitewings - four radiographic images | 4,712 | 4,693 | $33K |
| 82607 | 3,161 | 3,105 | $33K | |
| 87581 | 2,693 | 2,667 | $33K | |
| 82677 | 1,509 | 1,488 | $32K | |
| 82043 | 6,549 | 5,769 | $32K | |
| 86735 | 3,224 | 3,110 | $32K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 205 | 175 | $32K |
| 87522 | Neg quan hep c or qual rna | 787 | 759 | $31K |
| 83970 | 972 | 951 | $30K | |
| 12002 | 143 | 139 | $30K | |
| 73110 | 1,598 | 1,499 | $28K | |
| 73502 | 1,117 | 1,033 | $28K | |
| 94060 | 416 | 384 | $27K | |
| 86704 | 3,151 | 3,091 | $27K | |
| 82105 | 2,235 | 2,202 | $27K | |
| D0272 | Bitewings - two radiographic images | 5,668 | 5,667 | $27K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 1,079 | 903 | $25K |
| 90480 | 655 | 652 | $24K | |
| 82805 | 3,823 | 3,601 | $24K | |
| 81003 | 11,605 | 10,209 | $24K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 327 | 91 | $23K |
| 80320 | 9,762 | 9,059 | $23K | |
| 82274 | 1,757 | 1,748 | $22K | |
| D0330 | Panoramic radiographic image | 2,171 | 2,150 | $22K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 121 | 113 | $22K |
| 94729 | 387 | 386 | $21K | |
| 83550 | 3,336 | 3,274 | $21K | |
| 0072A | 506 | 506 | $21K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 3,362 | 3,177 | $21K |
| H0049 | Alcohol and/or drug screening | 310 | 284 | $21K |
| 97803 | 666 | 654 | $20K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 107 | 106 | $20K |
| 99383 | 263 | 262 | $20K | |
| 90674 | 1,727 | 1,710 | $20K | |
| 73562 | 902 | 827 | $19K | |
| 90707 | 1,144 | 1,141 | $19K | |
| 88142 | 867 | 857 | $19K | |
| 94726 | 284 | 283 | $19K | |
| 77080 | 607 | 586 | $19K | |
| 0071A | 485 | 483 | $19K | |
| D1351 | Sealant - per tooth | 2,167 | 751 | $19K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 611 | 264 | $18K |
| 83540 | 3,480 | 3,413 | $17K | |
| 90656 | 1,341 | 1,341 | $17K | |
| 86336 | 1,508 | 1,487 | $17K | |
| 90620 | 616 | 606 | $17K | |
| D8670 | Periodic orthodontic treatment visit | 1,092 | 1,043 | $17K |
| 3074F | 50,351 | 40,188 | $17K | |
| 92202 | 1,017 | 1,001 | $16K | |
| D0210 | Intraoral - complete series of radiographic images | 1,393 | 1,367 | $16K |
| 73590 | 1,151 | 1,117 | $16K | |
| 84207 | 577 | 574 | $16K | |
| 92557 | 504 | 502 | $16K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 14,801 | 13,966 | $15K |
| 96367 | 402 | 362 | $15K | |
| 99423 | 230 | 222 | $15K | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | 122 | 107 | $15K |
| 74018 | 753 | 746 | $15K | |
| 87081 | 3,144 | 3,102 | $15K | |
| 84703 | 2,636 | 2,574 | $15K | |
| J1631 | Injection, haloperidol decanoate, per 50 mg | 1,124 | 1,056 | $14K |
| 85730 | 7,745 | 7,498 | $14K | |
| 84704 | 1,114 | 1,095 | $14K | |
| 86003 | 470 | 420 | $14K | |
| 82570 | 5,261 | 4,099 | $14K | |
| J0401 | Injection, aripiprazole (abilify maintena), 1 mg | 25 | 24 | $14K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 384 | 373 | $13K |
| 90680 | 2,473 | 2,471 | $13K | |
| 88304 | 295 | 278 | $13K | |
| 11900 | 104 | 102 | $13K | |
| 99384 | 239 | 234 | $13K | |
| 73140 | 691 | 668 | $12K | |
| 84146 | 621 | 587 | $12K | |
| 81002 | 3,645 | 2,764 | $12K | |
| 88307 | 138 | 138 | $11K | |
| 90716 | 922 | 921 | $11K | |
| 99402 | 173 | 160 | $11K | |
| 73090 | 866 | 849 | $11K | |
| 84154 | 718 | 701 | $11K | |
| 87186 | 2,184 | 2,024 | $11K | |
| J0515 | Injection, benztropine mesylate, per 1 mg | 776 | 681 | $11K |
| 84484 | 10,577 | 9,554 | $11K | |
| 0124A | 291 | 288 | $11K | |
| 90744 | 1,943 | 1,939 | $10K | |
| 90633 | 1,897 | 1,896 | $10K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 65 | 53 | $10K |
| 83735 | 7,438 | 7,083 | $10K | |
| 87338 | 895 | 889 | $10K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 418 | 146 | $10K |
| J2785 | Injection, regadenoson, 0.1 mg | 56 | 54 | $10K |
| J7030 | Infusion, normal saline solution , 1000 cc | 14,661 | 13,748 | $9K |
| 99422 | 184 | 183 | $9K | |
| T1023 | Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter | 146 | 129 | $9K |
| 86592 | 2,920 | 2,648 | $9K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 190 | 188 | $9K |
| 93246 | 279 | 278 | $9K | |
| 29125 | 86 | 82 | $9K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 1,036 | 838 | $9K |
| 84402 | 354 | 337 | $9K | |
| 73560 | 263 | 240 | $8K | |
| 82977 | 1,395 | 1,344 | $8K | |
| 84425 | 462 | 460 | $8K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 5,484 | 5,170 | $8K |
| A9585 | Injection, gadobutrol, 0.1 ml | 236 | 236 | $8K |
| 59426 | 131 | 68 | $8K | |
| 86696 | 540 | 498 | $7K | |
| D1206 | Topical application of fluoride varnish | 1,342 | 1,334 | $7K |
| 96040 | 90 | 87 | $7K | |
| 83001 | 407 | 382 | $7K | |
| 86038 | 815 | 794 | $7K | |
| D0603 | 6,824 | 6,656 | $7K | |
| 84156 | 2,850 | 2,694 | $7K | |
| 90662 | 424 | 423 | $7K | |
| 99451 | 248 | 245 | $7K | |
| 83690 | 9,967 | 9,521 | $7K | |
| J2704 | Injection, propofol, 10 mg | 3,240 | 3,148 | $6K |
| 29130 | 54 | 52 | $6K | |
| 92551 | 965 | 965 | $6K | |
| 96380 | 392 | 392 | $6K | |
| 84100 | 2,614 | 2,526 | $6K | |
| 58300 | 62 | 61 | $6K | |
| 99406 | 739 | 711 | $6K | |
| 82785 | 458 | 450 | $6K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 2,819 | 2,774 | $6K |
| 90698 | 1,342 | 1,341 | $6K | |
| 86695 | 531 | 490 | $6K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 12 | 12 | $6K |
| 84403 | 209 | 193 | $5K | |
| 80165 | 1,010 | 967 | $5K | |
| D3330 | Endodontic therapy, molar tooth (excluding final restoration) | 44 | 41 | $5K |
| 83002 | 293 | 274 | $5K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 28 | 28 | $5K |
| 76000 | 26 | 26 | $5K | |
| 92201 | 385 | 363 | $5K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,333 | 1,301 | $5K |
| 90648 | 1,121 | 1,120 | $5K | |
| D9430 | 306 | 281 | $5K | |
| 3075F | 13,290 | 12,112 | $5K | |
| 86140 | 1,591 | 1,570 | $5K | |
| C1763 | Connective tissue, non-human (includes synthetic) | 60 | 60 | $5K |
| 73120 | 231 | 227 | $5K | |
| 84134 | 432 | 430 | $5K | |
| D0270 | 970 | 959 | $5K | |
| D1330 | 5,356 | 5,282 | $5K | |
| 86708 | 406 | 399 | $5K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 4,653 | 4,585 | $4K |
| 99382 | 59 | 59 | $4K | |
| 11981 | 24 | 24 | $4K | |
| 88141 | 266 | 258 | $4K | |
| 82746 | 436 | 427 | $4K | |
| 99232 | Subsequent hospital care, per day, moderate complexity | 233 | 100 | $4K |
| 72070 | 184 | 182 | $4K | |
| D9440 | 204 | 196 | $4K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 4,322 | 3,582 | $4K |
| 73620 | 168 | 164 | $4K | |
| 84590 | 386 | 384 | $4K | |
| 90653 | 240 | 240 | $4K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 80 | 76 | $4K |
| 82652 | 102 | 100 | $4K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 13 | 13 | $4K |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 3,285 | 3,098 | $4K |
| T2022 | Case management, per month | 96 | 81 | $4K |
| 3077F | 6,148 | 5,468 | $4K | |
| J3486 | Injection, ziprasidone mesylate, 10 mg | 236 | 202 | $4K |
| 92020 | 150 | 124 | $4K | |
| 94727 | 81 | 81 | $3K | |
| 85651 | 1,534 | 1,506 | $3K | |
| 71100 | 265 | 249 | $3K | |
| 90723 | 748 | 747 | $3K | |
| 83516 | 293 | 273 | $3K | |
| 82550 | 2,640 | 2,526 | $3K | |
| H2010 | Comprehensive medication services, per 15 minutes | 48 | 46 | $3K |
| 76642 | 42 | 41 | $3K | |
| 84481 | 266 | 256 | $3K | |
| Q3014 | Telehealth originating site facility fee | 1,047 | 885 | $3K |
| 73080 | 277 | 266 | $3K | |
| D9310 | 152 | 152 | $3K | |
| 82952 | 486 | 480 | $3K | |
| D0230 | Intraoral - periapical each additional radiographic image | 1,076 | 1,068 | $3K |
| 87517 | 65 | 63 | $3K | |
| 76536 | 25 | 25 | $3K | |
| 87521 | Neg quan hep c or qual rna | 71 | 71 | $3K |
| G0109 | Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | 201 | 197 | $3K |
| 86160 | 170 | 140 | $3K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 7,499 | 7,126 | $3K |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | 14 | 13 | $3K |
| 90694 | 188 | 188 | $3K | |
| 86255 | 275 | 259 | $3K | |
| 83883 | 135 | 122 | $2K | |
| 85045 | 844 | 802 | $2K | |
| J1953 | Injection, levetiracetam, 10 mg | 627 | 564 | $2K |
| 90836 | 25 | 24 | $2K | |
| 73070 | 208 | 206 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,688 | 3,593 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 4,923 | 4,720 | $2K |
| 87070 | 608 | 575 | $2K | |
| 84550 | 881 | 802 | $2K | |
| 93971 | 38 | 36 | $2K | |
| 82248 | 679 | 666 | $2K | |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | 57 | 41 | $2K |
| 86235 | 44 | 37 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 8,032 | 7,515 | $2K |
| 85379 | 1,654 | 1,629 | $2K | |
| J1630 | Injection, haloperidol, up to 5 mg | 4,226 | 3,760 | $2K |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 220 | 191 | $2K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 21 | 12 | $2K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 325 | 294 | $2K |
| 77062 | 13 | 13 | $2K | |
| 90736 | 13 | 13 | $2K | |
| D1354 | 936 | 370 | $2K | |
| 88313 | 31 | 29 | $2K | |
| 0012A | 97 | 97 | $2K | |
| D4341 | 65 | 36 | $2K | |
| 88112 | 24 | 24 | $2K | |
| 73600 | 103 | 100 | $2K | |
| 96160 | 171 | 161 | $2K | |
| 92227 | 105 | 105 | $2K | |
| 73552 | 147 | 143 | $2K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 902 | 893 | $2K |
| 73060 | 151 | 146 | $2K | |
| 90710 | 297 | 297 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,666 | 1,544 | $2K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,524 | 3,390 | $2K |
| 90681 | 190 | 190 | $1K | |
| 82948 | 525 | 487 | $1K | |
| 0011A | 100 | 95 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 863 | 828 | $1K |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,060 | 997 | $1K |
| 11056 | 13 | 13 | $1K | |
| 72190 | 74 | 73 | $1K | |
| 83605 | 1,413 | 1,351 | $1K | |
| 92002 | 14 | 13 | $1K | |
| 97014 | 65 | 24 | $1K | |
| 0081A | 33 | 33 | $1K | |
| 86376 | 86 | 81 | $1K | |
| 90700 | 216 | 216 | $1K | |
| 93226 | 26 | 26 | $1K | |
| 80178 | 375 | 358 | $1K | |
| 96376 | 1,118 | 1,089 | $1K | |
| 86705 | 147 | 145 | $1K | |
| 82784 | 60 | 50 | $997.67 | |
| 82010 | 1,321 | 1,222 | $974.49 | |
| 86141 | 134 | 134 | $962.24 | |
| 86225 | 98 | 97 | $954.14 | |
| J1756 | Injection, iron sucrose, 1 mg | 40 | 26 | $925.10 |
| 83615 | 314 | 302 | $921.37 | |
| 11055 | 12 | 12 | $917.84 | |
| 88300 | 74 | 71 | $915.80 | |
| 74022 | 67 | 64 | $901.18 | |
| 99173 | 573 | 573 | $874.48 | |
| 97168 | 13 | 13 | $833.29 | |
| 82803 | 495 | 461 | $821.16 | |
| 99397 | 25 | 25 | $809.72 | |
| 90696 | 205 | 205 | $772.21 | |
| 83525 | 57 | 43 | $766.86 | |
| 82670 | 28 | 25 | $760.82 | |
| D0191 | 712 | 706 | $757.48 | |
| D9990 | 74 | 65 | $755.50 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 222 | 213 | $739.36 |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | 17 | 12 | $735.85 |
| 86430 | 157 | 155 | $729.03 | |
| 82172 | 39 | 39 | $708.83 | |
| J7510 | Prednisolone oral, per 5 mg | 882 | 864 | $703.61 |
| 90672 | 191 | 191 | $701.59 | |
| J2060 | Injection, lorazepam, 2 mg | 2,928 | 2,566 | $699.87 |
| 90714 | 52 | 52 | $675.25 | |
| 83010 | 57 | 57 | $670.55 | |
| 82947 | 163 | 153 | $664.85 | |
| J1815 | Injection, insulin, per 5 units | 1,657 | 1,304 | $651.47 |
| 0031A | 18 | 18 | $646.67 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 7,529 | 6,572 | $637.59 |
| 92226 | 29 | 27 | $636.25 | |
| 93325 | 28 | 26 | $604.47 | |
| 81243 | 12 | 12 | $587.17 | |
| 80346 | 165 | 159 | $570.44 | |
| 0502F | 313 | 240 | $557.99 | |
| 94010 | 12 | 12 | $557.06 | |
| 97164 | 12 | 12 | $549.31 | |
| 86580 | 85 | 83 | $534.25 | |
| 90685 | 232 | 231 | $525.20 | |
| 90660 | 64 | 64 | $510.43 | |
| 96368 | 65 | 65 | $505.68 | |
| 90474 | 235 | 235 | $493.42 | |
| J7050 | Infusion, normal saline solution, 250 cc | 1,050 | 818 | $483.22 |
| D1320 | 72 | 72 | $472.00 | |
| 99429 | 157 | 127 | $467.50 | |
| 93307 | 69 | 68 | $464.22 | |
| 82247 | 107 | 97 | $456.09 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 473 | 467 | $456.08 |
| 82239 | 30 | 26 | $441.23 | |
| 82731 | 27 | 27 | $439.59 | |
| 0082A | 14 | 14 | $437.35 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,585 | 1,417 | $432.19 |
| 0074A | 12 | 12 | $426.30 | |
| 76820 | 19 | 17 | $420.30 | |
| 83718 | 195 | 195 | $418.85 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 85 | 85 | $402.77 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 5,874 | 5,205 | $402.13 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 3,046 | 2,788 | $394.04 |
| D8660 | 16 | 16 | $391.50 | |
| 85018 | 191 | 188 | $382.39 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 323 | 285 | $368.03 |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 17 | 17 | $364.22 |
| 85014 | 180 | 177 | $355.08 | |
| 85307 | 26 | 26 | $352.91 | |
| 97018 | 40 | 12 | $346.21 | |
| 99238 | Hospital discharge day management, 30 minutes or less | 12 | 12 | $343.34 |
| 81015 | 126 | 123 | $341.40 | |
| 91318 | 16 | 16 | $336.38 | |
| 73100 | 12 | 12 | $331.27 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 510 | 472 | $323.72 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 787 | 764 | $321.00 |
| 84478 | 194 | 194 | $316.08 | |
| 82465 | 217 | 217 | $311.33 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 499 | 328 | $309.76 |
| D0160 | 13 | 13 | $302.20 | |
| 87420 | 158 | 155 | $302.12 | |
| 87205 | 156 | 145 | $301.26 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 12 | 12 | $295.19 |
| 90678 | 14 | 14 | $284.74 | |
| 87075 | 63 | 59 | $268.20 | |
| G0008 | Administration of influenza virus vaccine | 596 | 594 | $259.81 |
| 85384 | 93 | 82 | $250.21 | |
| 1159F | 5,332 | 3,626 | $243.29 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 57 | 56 | $229.47 |
| 82150 | 258 | 250 | $226.61 | |
| 87400 | 39 | 38 | $224.46 | |
| 90473 | 120 | 120 | $220.85 | |
| 72040 | 13 | 13 | $210.12 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 199 | 163 | $210.09 |
| 73660 | 12 | 12 | $206.43 | |
| 80349 | 19 | 18 | $204.16 | |
| 1126F | 52 | 28 | $203.76 | |
| 85660 | 43 | 43 | $197.21 | |
| 99152 | 14 | 14 | $192.40 | |
| 3078F | 53,654 | 42,580 | $188.76 | |
| 84132 | 65 | 63 | $178.26 | |
| 85306 | 12 | 12 | $162.38 | |
| 85303 | 13 | 13 | $161.90 | |
| 94761 | 52 | 51 | $157.60 | |
| 82103 | 12 | 12 | $156.68 | |
| 90381 | 48 | 48 | $151.50 | |
| 3079F | 14,284 | 12,895 | $142.64 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 49 | 48 | $139.57 |
| 85300 | 14 | 14 | $138.69 | |
| 99446 | 12 | 12 | $131.23 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3,424 | 3,370 | $130.64 |
| 86880 | 20 | 14 | $129.16 | |
| 85305 | 12 | 12 | $123.06 | |
| 84436 | 116 | 113 | $119.69 | |
| 90671 | 23 | 23 | $107.99 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 128 | 125 | $100.33 |
| 84112 | 26 | 24 | $94.27 | |
| J0290 | Injection, ampicillin sodium, 500 mg | 69 | 69 | $84.04 |
| 91319 | 12 | 12 | $77.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 30 | 30 | $74.38 |
| 82272 | 43 | 42 | $68.97 | |
| J1644 | Injection, heparin sodium, per 1000 units | 154 | 111 | $55.74 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 12 | 12 | $51.66 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 35 | 35 | $49.66 |
| J3411 | Injection, thiamine hcl, 100 mg | 66 | 65 | $49.60 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 13 | 13 | $48.81 |
| 87040 | 59 | 48 | $48.36 | |
| 87088 | 231 | 225 | $48.06 | |
| 84460 | 16 | 16 | $44.49 | |
| 82397 | 18 | 18 | $29.18 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 25 | 25 | $29.09 |
| 94760 | 513 | 445 | $25.66 | |
| 92225 | 266 | 147 | $19.66 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 19 | 18 | $17.82 |
| 87071 | 95 | 94 | $16.64 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 95 | 79 | $15.89 |
| J1170 | Injection, hydromorphone, up to 4 mg | 42 | 40 | $6.77 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 16 | 16 | $4.31 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 12 | 12 | $0.93 |
| J3480 | Injection, potassium chloride, per 2 meq | 17 | 14 | $0.20 |
| 1160F | 3,639 | 2,789 | $0.00 | |
| 99499 | 4,665 | 3,447 | $0.00 | |
| D0190 | 781 | 781 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 31 | 31 | $0.00 |
| 2022F | 69 | 64 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 444 | 434 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 45 | 45 | $0.00 |
| 99080 | 1,575 | 262 | $0.00 | |
| 99195 | 158 | 153 | $0.00 | |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | 172 | 168 | $0.00 |
| 99408 | 32 | 32 | $0.00 | |
| 3725F | 36 | 33 | $0.00 | |
| G0445 | High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes | 33 | 33 | $0.00 |
| 48510 | 750 | 735 | $0.00 | |
| 3080F | 2,096 | 1,946 | $0.00 | |
| 4293F | 102 | 102 | $0.00 | |
| 80050 | General health panel | 590 | 589 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 12 | 12 | $0.00 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 439 | 439 | $0.00 |
| 3044F | 13 | 13 | $0.00 | |
| 1170F | 141 | 138 | $0.00 | |
| 86707 | 25 | 25 | $0.00 | |
| 1220F | 288 | 288 | $0.00 | |
| D1310 | 330 | 330 | $0.00 | |
| 84479 | 14 | 14 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 76 | 76 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 12 | 12 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 21 | 15 | $0.00 |
| 87350 | 25 | 25 | $0.00 | |
| 90647 | 37 | 37 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 12 | 12 | $0.00 |